U-S Keeping an Eye on Canada's Plan on Drug Pricing

U-S keeping an eye on Canada's plan on prescription drug pricing

The United States is keeping Canada and its plans to overhaul its drug-pricing system on a ``watch list'' of countries deemed a peril to American intellectual property rights. In its annual report on foreign threats to U-S copyright holders, the office of the U-S Trade Representative raises concerns about Canada's plan to change how it calculates the fair price of prescription drugs.